The effectiveness of a sensor-controlled scalp cooling system, DigniCap, appears to depend on the type of chemotherapy regimen and the patient's age.
Why this matters
Hair loss is a common and very distressing adverse effect of chemotherapy, and effective preventive interventions are needed.
Prospective study that involved 55 women who receive neoadjuvant, adjuvant, or palliative chemotherapy for breast or gynecologic cancer; the goal was to evaluate the effectiveness of a sensor-controlled scalp cooling system (DigniCap) to prevent chemotherapy-induced alopecia.
Funding: None disclosed.
Overall level of effectiveness of the treatment (per World Health Organization alopecia grading system) was 56%, including patients who stopped treatment early.